PATENT CLAIM ANALYSIS

Application Number: 15872057
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "322000"]

Abstract:
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

Claim (Index 27):
The compound of any one of  claims 16 - 26 , wherein R is \u2014H.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 86.0
- Lexical Diversity: 2.65385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13918048', '15177546', '14305393', '14099054', '14666567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7908466072174917
- 35 USC 102 Novelty (BERT): 0.5330478878775916
- Combined Prediction Score: 0.7650667352835017
- Mean Citation Score: 315.9048640000001
- Max Citation Score: 350.91568
- Similarity Product: 218.47067581951143

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test